Arjen Quirinus Bakker

Title: Arjen Quirinus Bakker: Innovator in Influenza A Virus Antibodies

Introduction

Arjen Quirinus Bakker is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of medical science, particularly in the development of antibodies for influenza A virus. His work is crucial in the ongoing battle against viral infections.

Latest Patents

Bakker holds a patent for "Influenza A virus specific antibodies." This invention relates to isolated, synthetic, or recombinant antibodies and functional parts thereof that are specific for multiple influenza A virus subtypes. The patent further details the use of these antibodies for diagnosing influenza A virus infections and as a medicament or prophylactic agent for treating or alleviating symptoms associated with such infections. He has 1 patent to his name.

Career Highlights

Arjen Quirinus Bakker is associated with Aimm Therapeutics B.V., where he continues to work on innovative solutions in the field of virology. His expertise and dedication to research have positioned him as a key figure in the development of therapeutic agents against influenza.

Collaborations

Bakker collaborates with talented professionals in his field, including Hergen Spits and Tim Beaumont. Their combined efforts contribute to advancing research and development in antibody therapies.

Conclusion

Arjen Quirinus Bakker's work in developing influenza A virus specific antibodies showcases his commitment to improving public health through innovation. His contributions are vital in the fight against viral infections, and his ongoing research promises to yield further advancements in medical science.